Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refining Multidrug Tuberculosis Treatment with the Ultra Short All Oral Regimen

NCT03867136 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT03867136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03867136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refining Multidrug Tuberculosis Treatment with the Ultra Short All Oral Regimen
Lead sponsor
Huashan Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2020
Completion date
August 10, 2024
Enrollment
354 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug resistant tuberculosis